[1]
2022. Formulation and Characterization of Imatinib Mesylate Liposomes in Gel for Intraarticular administration. International Journal of Pharmaceutical Sciences and Drug Research. 14, 5 (Sep. 2022), 559–566. DOI:https://doi.org/10.25004/IJPSDR.2022.140508.